Report Detail

Request for Sample of this report

Other Global Therapeutic Recombinant Protein Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4524755
    • |
  • 27 March, 2023
    • |
  • Global
    • |
  • 114 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Therapeutic Recombinant Protein market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Therapeutic recombinant proteins are proteins that are produced by recombinant DNA technology and are used as drugs to treat various medical conditions. Recombinant DNA technology involves the use of genetically engineered microorganisms or cells to produce large quantities of a specific protein that has therapeutic potential. Therapeutic recombinant proteins are used to treat a wide range of medical conditions, including cancer, autoimmune diseases, genetic disorders, and infectious diseases. These proteins are designed to mimic the natural proteins in the body that regulate various biological processes. They are often administered by injection, and their effectiveness depends on the specific protein and the medical condition being treated.
This report is a detailed and comprehensive analysis for global Therapeutic Recombinant Protein market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Therapeutic Recombinant Protein market size and forecasts, in consumption value ($ Million), 2018-2029
Global Therapeutic Recombinant Protein market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Therapeutic Recombinant Protein market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Therapeutic Recombinant Protein market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Therapeutic Recombinant Protein
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Therapeutic Recombinant Protein market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcam, HALIX, Avantor, Miltenyi Biotec and Thermo Fisher Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Therapeutic Recombinant Protein market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hormones
Blood Clotting Factors
Cytokines
Enzymes
Fusion Proteins
Others
Market segment by Application
Pharmaceutical Company
Research Institute
Others
Market segment by players, this report covers
Abcam
HALIX
Avantor
Miltenyi Biotec
Thermo Fisher Scientific
Bio-Techne Corporation
Merck
ACROBiosystems
Abnova
Eurogentec (Kaneka Corporation)
Cytiva (Danaher )
Reprocell
GenScript
BPS Bioscience
Sino Biological
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Therapeutic Recombinant Protein product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Recombinant Protein, with revenue, gross margin and global market share of Therapeutic Recombinant Protein from 2018 to 2023.
Chapter 3, the Therapeutic Recombinant Protein competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Therapeutic Recombinant Protein market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Recombinant Protein.
Chapter 13, to describe Therapeutic Recombinant Protein research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Therapeutic Recombinant Protein
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Therapeutic Recombinant Protein by Type
    • 1.3.1 Overview: Global Therapeutic Recombinant Protein Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Therapeutic Recombinant Protein Consumption Value Market Share by Type in 2022
    • 1.3.3 Hormones
    • 1.3.4 Blood Clotting Factors
    • 1.3.5 Cytokines
    • 1.3.6 Enzymes
    • 1.3.7 Fusion Proteins
    • 1.3.8 Others
  • 1.4 Global Therapeutic Recombinant Protein Market by Application
    • 1.4.1 Overview: Global Therapeutic Recombinant Protein Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Pharmaceutical Company
    • 1.4.3 Research Institute
    • 1.4.4 Others
  • 1.5 Global Therapeutic Recombinant Protein Market Size & Forecast
  • 1.6 Global Therapeutic Recombinant Protein Market Size and Forecast by Region
    • 1.6.1 Global Therapeutic Recombinant Protein Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Therapeutic Recombinant Protein Market Size by Region, (2018-2029)
    • 1.6.3 North America Therapeutic Recombinant Protein Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Therapeutic Recombinant Protein Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Therapeutic Recombinant Protein Market Size and Prospect (2018-2029)
    • 1.6.6 South America Therapeutic Recombinant Protein Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Therapeutic Recombinant Protein Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Abcam
    • 2.1.1 Abcam Details
    • 2.1.2 Abcam Major Business
    • 2.1.3 Abcam Therapeutic Recombinant Protein Product and Solutions
    • 2.1.4 Abcam Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Abcam Recent Developments and Future Plans
  • 2.2 HALIX
    • 2.2.1 HALIX Details
    • 2.2.2 HALIX Major Business
    • 2.2.3 HALIX Therapeutic Recombinant Protein Product and Solutions
    • 2.2.4 HALIX Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 HALIX Recent Developments and Future Plans
  • 2.3 Avantor
    • 2.3.1 Avantor Details
    • 2.3.2 Avantor Major Business
    • 2.3.3 Avantor Therapeutic Recombinant Protein Product and Solutions
    • 2.3.4 Avantor Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Avantor Recent Developments and Future Plans
  • 2.4 Miltenyi Biotec
    • 2.4.1 Miltenyi Biotec Details
    • 2.4.2 Miltenyi Biotec Major Business
    • 2.4.3 Miltenyi Biotec Therapeutic Recombinant Protein Product and Solutions
    • 2.4.4 Miltenyi Biotec Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Miltenyi Biotec Recent Developments and Future Plans
  • 2.5 Thermo Fisher Scientific
    • 2.5.1 Thermo Fisher Scientific Details
    • 2.5.2 Thermo Fisher Scientific Major Business
    • 2.5.3 Thermo Fisher Scientific Therapeutic Recombinant Protein Product and Solutions
    • 2.5.4 Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.6 Bio-Techne Corporation
    • 2.6.1 Bio-Techne Corporation Details
    • 2.6.2 Bio-Techne Corporation Major Business
    • 2.6.3 Bio-Techne Corporation Therapeutic Recombinant Protein Product and Solutions
    • 2.6.4 Bio-Techne Corporation Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Bio-Techne Corporation Recent Developments and Future Plans
  • 2.7 Merck
    • 2.7.1 Merck Details
    • 2.7.2 Merck Major Business
    • 2.7.3 Merck Therapeutic Recombinant Protein Product and Solutions
    • 2.7.4 Merck Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Merck Recent Developments and Future Plans
  • 2.8 ACROBiosystems
    • 2.8.1 ACROBiosystems Details
    • 2.8.2 ACROBiosystems Major Business
    • 2.8.3 ACROBiosystems Therapeutic Recombinant Protein Product and Solutions
    • 2.8.4 ACROBiosystems Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 ACROBiosystems Recent Developments and Future Plans
  • 2.9 Abnova
    • 2.9.1 Abnova Details
    • 2.9.2 Abnova Major Business
    • 2.9.3 Abnova Therapeutic Recombinant Protein Product and Solutions
    • 2.9.4 Abnova Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Abnova Recent Developments and Future Plans
  • 2.10 Eurogentec (Kaneka Corporation)
    • 2.10.1 Eurogentec (Kaneka Corporation) Details
    • 2.10.2 Eurogentec (Kaneka Corporation) Major Business
    • 2.10.3 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product and Solutions
    • 2.10.4 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Eurogentec (Kaneka Corporation) Recent Developments and Future Plans
  • 2.11 Cytiva (Danaher )
    • 2.11.1 Cytiva (Danaher ) Details
    • 2.11.2 Cytiva (Danaher ) Major Business
    • 2.11.3 Cytiva (Danaher ) Therapeutic Recombinant Protein Product and Solutions
    • 2.11.4 Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Cytiva (Danaher ) Recent Developments and Future Plans
  • 2.12 Reprocell
    • 2.12.1 Reprocell Details
    • 2.12.2 Reprocell Major Business
    • 2.12.3 Reprocell Therapeutic Recombinant Protein Product and Solutions
    • 2.12.4 Reprocell Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Reprocell Recent Developments and Future Plans
  • 2.13 GenScript
    • 2.13.1 GenScript Details
    • 2.13.2 GenScript Major Business
    • 2.13.3 GenScript Therapeutic Recombinant Protein Product and Solutions
    • 2.13.4 GenScript Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 GenScript Recent Developments and Future Plans
  • 2.14 BPS Bioscience
    • 2.14.1 BPS Bioscience Details
    • 2.14.2 BPS Bioscience Major Business
    • 2.14.3 BPS Bioscience Therapeutic Recombinant Protein Product and Solutions
    • 2.14.4 BPS Bioscience Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 BPS Bioscience Recent Developments and Future Plans
  • 2.15 Sino Biological
    • 2.15.1 Sino Biological Details
    • 2.15.2 Sino Biological Major Business
    • 2.15.3 Sino Biological Therapeutic Recombinant Protein Product and Solutions
    • 2.15.4 Sino Biological Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Sino Biological Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Therapeutic Recombinant Protein Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Therapeutic Recombinant Protein by Company Revenue
    • 3.2.2 Top 3 Therapeutic Recombinant Protein Players Market Share in 2022
    • 3.2.3 Top 6 Therapeutic Recombinant Protein Players Market Share in 2022
  • 3.3 Therapeutic Recombinant Protein Market: Overall Company Footprint Analysis
    • 3.3.1 Therapeutic Recombinant Protein Market: Region Footprint
    • 3.3.2 Therapeutic Recombinant Protein Market: Company Product Type Footprint
    • 3.3.3 Therapeutic Recombinant Protein Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Therapeutic Recombinant Protein Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Therapeutic Recombinant Protein Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Therapeutic Recombinant Protein Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Therapeutic Recombinant Protein Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Therapeutic Recombinant Protein Consumption Value by Type (2018-2029)
  • 6.2 North America Therapeutic Recombinant Protein Consumption Value by Application (2018-2029)
  • 6.3 North America Therapeutic Recombinant Protein Market Size by Country
    • 6.3.1 North America Therapeutic Recombinant Protein Consumption Value by Country (2018-2029)
    • 6.3.2 United States Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Therapeutic Recombinant Protein Consumption Value by Type (2018-2029)
  • 7.2 Europe Therapeutic Recombinant Protein Consumption Value by Application (2018-2029)
  • 7.3 Europe Therapeutic Recombinant Protein Market Size by Country
    • 7.3.1 Europe Therapeutic Recombinant Protein Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 7.3.3 France Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Therapeutic Recombinant Protein Market Size by Region
    • 8.3.1 Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Region (2018-2029)
    • 8.3.2 China Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 8.3.5 India Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Therapeutic Recombinant Protein Consumption Value by Type (2018-2029)
  • 9.2 South America Therapeutic Recombinant Protein Consumption Value by Application (2018-2029)
  • 9.3 South America Therapeutic Recombinant Protein Market Size by Country
    • 9.3.1 South America Therapeutic Recombinant Protein Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Therapeutic Recombinant Protein Market Size by Country
    • 10.3.1 Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Therapeutic Recombinant Protein Market Drivers
  • 11.2 Therapeutic Recombinant Protein Market Restraints
  • 11.3 Therapeutic Recombinant Protein Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Therapeutic Recombinant Protein Industry Chain
  • 12.2 Therapeutic Recombinant Protein Upstream Analysis
  • 12.3 Therapeutic Recombinant Protein Midstream Analysis
  • 12.4 Therapeutic Recombinant Protein Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Therapeutic Recombinant Protein. Industry analysis & Market Report on Therapeutic Recombinant Protein is a syndicated market report, published as Global Therapeutic Recombinant Protein Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Therapeutic Recombinant Protein market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,735.28
    		4,102.92
    		5,470.56
    		3,288.60
    		4,932.90
    		6,577.20
    		540,096.00
    		810,144.00
    		1,080,192.00
    		293,851.20
    		440,776.80
    		587,702.40
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo